Wary of timings21 Jan 2014 21:40
I agree, the new year should bring the update and nothing so far. Impossible to read, could be ahead or behind schedule and nothing we can do but expect update once tests are finalised in any direction.
The company will maintain a certain value based on profit levels and other aspect, the significant value is in CD4 and people await more concrete knowledge. I find many don't invest in AIM, are willing to miss the initial increase until more facts are given and success assured. We get in cheaper now but certain hold an enormas risk compared to when announcements come.